Cargando…
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
Crimean-Congo hemorrhagic fever virus (CCHFV; family Nairoviridae) is a tick-borne pathogen that frequently causes lethal disease in humans. CCHFV has a wide geographic distribution, and cases have been reported in Africa, Asia, the Middle East, and Europe. Availability of a safe and efficacious vac...
Autores principales: | Scholte, F. E. M., Karaaslan, E., O’Neal, T. J., Sorvillo, T. E., Genzer, S. C., Welch, S. R., Coleman-McCray, J. D., Spengler, J. R., Kainulainen, M. H., Montgomery, J. M., Pegan, S. D., Bergeron, E., Spiropoulou, C. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475602/ https://www.ncbi.nlm.nih.gov/pubmed/37671145 http://dx.doi.org/10.3389/fcimb.2023.1233148 |
Ejemplares similares
-
Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
por: Scholte, Florine E. M., et al.
Publicado: (2019) -
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination
por: Welch, Stephen R., et al.
Publicado: (2023) -
Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection
por: Scholte, Florine E. M., et al.
Publicado: (2019) -
Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus
por: Zivcec, Marko, et al.
Publicado: (2016) -
The Crimean-Congo Hemorrhagic Fever Virus NSm Protein Is Dispensable for Growth In Vitro and Disease in Ifnar(-/-) Mice
por: Welch, Stephen R., et al.
Publicado: (2020)